Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Central Hospital, Nancy, France
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Type 2 diabetes mellitus
Patients who had undergone a VCTE examen at Universitary Hospital of Nancy between January 1st, 2014 and December 31th, 2019
\- Patients who had undergone a DEXA at Universitary Hospital of Nancy with less than one year of difference with VCTE
You may not be if
Viral, ethylic, drug-linked, genetic, self-immune hepatitis, liver cancer or metatasis ; other causes who could interact with fibroscan or biological markers (thrombocytopenia, undernutrition)
Type 1 diabetes mellitus
Weight variation (\>5% of body weight) between DEXA mesure and Fibroscan mesure
Fail of VCTE examination
High alcohol consumption (\>30g/day for men and \>20g.day for women)
Pregnant women
Other causes of secondary hepatic steatosis (drug-linked, parenteral nutrition, rare diseases...)
Any other pathology that the investigator would consider not compatible with the research
Patients in any other research protocol three months before inclusion
Person referred as in the Public Health code (articles L.1121-5, L.1121-7 and L.1121-8) : pregnant or nursing woman, minor adult, major adult under legal protection, adult unable of giving consent
Person deprived of their liberty by judicial or administrative decision, person under psychiatric care as described in articles L. 3212-1 and L.3213-1.
Clareo Health | Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
